Adrenal Hypercortisolism: A Closer Look at Screening, Diagnosis, and Important Considerations of Different Testing Modalities
Open accessThe DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
Abstract
Although prolonged hypercortisolism is associated with increased mortality and substantial morbidity, the clinical signs and symptoms are wide ranging and often nonspecific, contributing to challenges in diagnosis, as well as treatment delays. Greater awareness is needed among clinicians to help identify which patients should undergo biochemical screening for excess cortisol. Several biochemical tests are available, each with important caveats that should be considered in the context of the individual patient. Cortisol secretion varies widely, further complicating the biochemical diagnosis of hypercortisolism, which relies on the use of definitive cutoff values. Patients with hypercortisolism resulting from adrenal adenomas, including those discovered incidentally, often do not present with overt Cushingoid features (plethora, striae, muscle weakness, moon facies, etc.). However, the consequences of prolonged exposure to even slight elevations in cortisol levels are profound, including increased risk of diabetes, hypertension, fractures, cardiovascular events, and mortality. Because most cases of hypercortisolism resulting from an adrenal adenoma can be managed, it is imperative to identify patients at risk and initiate testing early for the best outcomes. The aim of this report is to increase awareness of the indications for screening for hypercortisolism and to review the biochemical screening tests and diagnosis for hypercortisolism associated with adrenal adenomas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“EIA-F, LCMS-F, or LCMS-E have poor sensitivity for the diagnosis of cortisol excess in patients with adrenal incidentalomas and/or mild cortisol excess [56, 65, 74]”
From Prospective Evaluation of Late-Night Salivary Cortisol and Cortisone by EIA and LC-MS/MS in Suspected Cushing Syndrome (2020) · cites this paper as [74]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718 · cited 10×
“Patients with newly discovered adrenal adenomas and/or signs and symptoms leading to a suspicion of hypercortisolism should undergo biochemical screening [11].”
BackgroundMethodInfluentialFassnacht, M., Arlt, W., Bancos, I., Dralle, H., Newell-Price, J., Sahdev, A., Tabarin, A., Terzolo, M., Tsagarakis, S., & Dekkers, O. M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0467 · Cited by 1,566 · cited 5×
“Whereas the most recent clinical guidelines regarding diagnosis of hypercortisolism in patients with adrenal incidentalomas, from 2016, suggest that patients undergo screening with the ODST [8], a recent study of 57 centers from 26 European countries found that testing protocols varied considerably across practices [5…”
BackgroundInfluentialTreatment of Cushing's syndrome: an Endocrine Society clinical practice guideline
Nieman, L. K., Biller, B. M. K., Findling, J. W., Murad, M. H., Newell-Price, J., Savage, M. O., & Tabarin, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1818 · Cited by 1,270
OMURA, M., SAITO, J., YAMAGUCHI, K., KAKUTA, Y., & NISHIKAWA, T. (2004) · Hypertension Research · doi:10.1291/hypres.27.193 · Cited by 562 · cited 1×
“The prevalence of hypercortisolism in the general hypertensive patient population has been reported as ;1% [22], although a higher rate (8%) has been reported in patients with resistant hypertension (i.”
BackgroundCharacterization of the normal temporal pattern of plasma corticosteroid levels.
KRIEGER, D. T., ALLEN, W., RIZZO, F., & KRIEGER, H. P. (1971) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-32-2-266 · Cited by 549 · cited 1×
“Cortisol levels are expected to peak upon awakening in the morning (0700 to 0900 hours) and taper off during the day and are at their lowest during the late night (2300 to 0100 hours) [31, 32].”
BackgroundDi Dalmazi, G., Vicennati, V., Garelli, S., Casadio, E., Rinaldi, E., Giampalma, E., Mosconi, C., Golfieri, R., Paccapelo, A., Pagotto, U., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70211-0 · Cited by 415
Valassi, E., Santos, A., Yaneva, M., Tóth, M., Strasburger, C. J., Chanson, P., Wass, J. A. H., Chabre, O., Pfeifer, M., Feelders, R. A., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0272 · Cited by 402
Tauchmanovà, L., Rossi, R., Biondi, B., Pulcrano, M., Nuzzo, V., Palmieri, E.-A., Fazio, S., & Lombardi, G. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011766 · Cited by 400
ROSS, E. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92749-0 · Cited by 390
Management of Incidental Adrenal Masses: A White Paper of the ACR Incidental Findings Committee
Mayo-Smith, W. W., Song, J. H., Boland, G. L., Francis, I. R., Israel, G. M., Mazzaglia, P. J., Berland, L. L., & Pandharipande, P. V. (2017) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2017.05.001 · Cited by 362 · cited 1×
“Various radiology and clinical guidelines have suggested routine clinical and hormonal workup for incidentally discovered adrenal adenomas [12].”
Background
Cited by
Hair cortisol concentration as a biomarker of parental burnout
Brianda, M. E., Roskam, I., & Mikolajczak, M. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104681 · Cited by 121
Morelli, V., Frigerio, S., Aresta, C., Passeri, E., Pugliese, F., Copetti, M., Barbieri, A. M., Fustinoni, S., Polledri, E., Corbetta, S., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.898084 · Cited by 68
Self-citationIacopo, C., Falchetti, A., Merlotti, D., Cristina, E.-V., & Gennari, L. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2020.1772051 · Cited by 64
Treatment options for glucocorticoid-induced osteoporosis
Chiodini, I., Merlotti, D., Falchetti, A., & Gennari, L. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1721467 · Cited by 48
“If this data is confirmed, drugs able to act on the 11βhydroxysteroid-dehydrogenase enzymes may be developed for curing osteoporosis, not only in patients with GC excess, but also in those cases of high GC sensitivity [114,115].”
BackgroundSelf-citationVogg, N., Kurlbaum, M., Deutschbein, T., Gräsl, B., Fassnacht, M., & Kroiss, M. (2021) · Clinical Chemistry · doi:10.1093/clinchem/hvab056 · Cited by 38
“there is an ongoing debate about the best test strategy in this setting (12).”
Background
Metadata
- Authors
- Chiodini, I., Ramos-Rivera, A., Marcus, A. O., & Yau, H.
- Affiliations
- University of Milan (IT)
- Department of Internal Medicine, University of Central Florida College of Medicine, Orlando, Florida
- South Orange County Endocrinology, Laguna Hills, California
- University of California, San Francisco (US)
- Corresponding author
- Yau, Hanford
- Venue
- Journal of the Endocrine Society
- Publisher
- The Endocrine Society
- Published
- 2019-04-11
- Volume
- 3
- Issue
- 5
- Pages
- 1097-1109
- ISSN
- 2472-1972 (ISSN-L)
- PMC
- PMC6500795
- OpenAlex
- W2939101516
- Cited by
- 25
- References
- 62
- Citations by year
- 2026: 3 · 2025: 3 · 2023: 3 · 2022: 6 · 2021: 4 · 2020: 6
- FWCI
- 0.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of the Endocrine Society (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Funders
- Amgen
- Regeneron Pharmaceuticals
- MannKind Corporation
- Italfarmaco
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- Cushing's syndrome, adrenal adenoma, biochemical screening, cortisol measurement, diagnostic thresholds, Cushingoid features, screening indications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adrenal Hypercortisolism: A Closer Look at Screening, Diagnosis, and Important Considerations of Different Testing Modalities. https://app.cochat.ai/papers/10.1210/js.2018-00382
- The paper
- Chiodini, I., Ramos-Rivera, A., Marcus, A. O., & Yau, H. (2019). Adrenal Hypercortisolism: A Closer Look at Screening, Diagnosis, and Important Considerations of Different Testing Modalities. Journal of the Endocrine Society. https://doi.org/10.1210/js.2018-00382
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.